Skip to content
GenoLensGenoLens

GK

Chr Xp21.2

glycerol kinase

Aliases:
GK1, GKD
MANE:
ENST00000427190.6

Annotations refreshed 1 month ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Diagnostic Grade (Green)

  • DDG2P

    X-LINKED: hemizygous mutation in males, biallelic mutations in females
  • Intellectual disability

    X-LINKED: hemizygous mutation in males, biallelic mutations in females
  • Likely inborn error of metabolism

    X-LINKED: hemizygous mutation in males, biallelic mutations in females
  • Undiagnosed metabolic disorders

    X-LINKED: hemizygous mutation in males, biallelic mutations in females
  • Childhood onset dystonia, chorea or related movement disorder

  • Fetal anomalies

    X-LINKED: hemizygous mutation in males, biallelic mutations in females

Disease associations (Open Targets)

  • isolated glycerol kinase deficiency

    0.74
  • Glycerol kinase deficiency

    0.73
  • inborn glycerol kinase deficiency

    0.72
  • hereditary disease

    0.40
  • glycerol kinase deficiency, adult form

    0.37
  • glycerol kinase deficiency, juvenile form

    0.37
  • Global developmental delay

    0.12
  • Absent speech

    0.12
  • Seizure

    0.12
  • type 2 diabetes mellitus

    0.07

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

Glycerol kinase

Kinase that plays a key role in glycerol metabolism, catalyzing its phosphorylation to produce sn-glycerol 3-phosphate. Sn-glycerol 3-phosphate is a crucial intermediate in various metabolic pathways, such as the synthesis of glycerolipids and triglycerides, glycogenesis, glycolysis and gluconeogenesis

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.